RAB5C, member RAS oncogene family pseudogene 1Genealiases: []
Q-omics provides the consensus-scored RAB5CP1 profile across patient tissues and cancer cell-line models. RAB5CP1 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in CESC. Among the 18 cancer types available for tumor–normal comparison, RAB5CP1 is differentially expressed in 2, with the highest sampling consensus in HNSC. Additionally, RAB5CP1 RNA expression shows 9,054 significant protein co-abundance associations, with the highest sampling consensus in LUAD. Together, these results highlight CESC, HNSC, and LUAD as cancer lineages where RAB5CP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RAB5CP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RAB5CP1 survival associations across molecular data types. RAB5CP1 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RAB5CP1 RNA expression–survival associations across cancer types. High RAB5CP1 expression shows unfavorable associations in CESC, KIRC, COAD and ACC, but favorable associations in KIRP and LUAD. The CESC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify CESC as the clearest survival context for RAB5CP1 RNA expression.
This table summarizes RAB5CP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RAB5CP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RAB5CP1 shows higher tumor expression in HNSC and COAD. The HNSC box plot shows higher RAB5CP1 RNA expression in tumor versus normal tissue (log2 FC = +0.096, t-test p = .001).
This table shows molecular features associated with RAB5CP1 in patient tissues and cancer cell lines. In patient samples, RAB5CP1 shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set.
